MetLife (MET) came out with quarterly earnings of $1.93 per share, missing the Zacks Consensus Estimate of $2.16 per share. This compares to earnings of $1.97 per share a year ago.
MET's third-quarter earnings are likely to have benefited from rising premiums and investment income.
Besides Wall Street's top -and-bottom-line estimates for MetLife (MET), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2024.
Drew Matus, MetLife Investment Management chief market strategist, joins 'Money Movers' to discuss Matus' expectations for the Federal Reserve the rest of this year, if inflation is flaring back up, and much more.
MetLife (MET) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New York-based insurer MetLife Inc is in advanced talks to buy PineBridge Investments' assets outside of China in a deal that could be valued at $1 billion to $1.5 billion, Bloomberg News reported on Monday.
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MetLife (MET) have what it takes?
Drew Matus, MetLife Investment Management chief market strategist, joins CNBC's 'Money Movers' to discuss the markets, whether inflation returning back to 2% matters, his outlook for the economy, and more.
On September 30, 2024, MetLife Investment Management, LLC (Trades, Portfolio) made a significant move in the financial markets by acquiring 840,000 shares of CALAMOS CONVERTIBLE OPPORTUNITIES & INCOME FUND (CHI, Financial). This transaction marked a new holding for the firm, purchased at a price of $11.64 per share.
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MetLife (MET) have what it takes?
MetLife's strong financial performance, with a 17.5% increase in adjusted EPS and a 15.2% rise in book value, makes it an attractive investment. Despite comparable performance to Aflac, MetLife's lower valuation offers better value for shareholders. MetLife's growing dividend yield and robust share buyback program enhance shareholder value, with ample cash reserves supporting future buybacks.
Here is how MetLife (MET) and Popular (BPOP) have performed compared to their sector so far this year.